Delivery Order SPE2DB20D3101-SPE2DB23FRNY9

Award Date 6/9/23
Potential Completion Date 6/12/23
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL syringes to the Defense Logistics Agency (DLA). The $1,465.38 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 4, 2021 and was awarded on August 3, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL pharmaceutical products to the Defense Logistics Agency (DLA). The $1,187.60 fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,445.91 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the company's Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999 through December 2025. The contract has no set-aside designation and is intended to support medical treatment...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL injection to the Defense Logistics Agency (DLA). The $1,792.97 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division. This IDC...
This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml medication to the Defense Logistics Agency (DLA). The $1,706.28 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 13, 2023 and was awarded on September 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/ml 3ml medication. The $4,308.37 firm fixed-price contract has a completion date of March 9, 2023. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for...
This federal contract award is for the delivery of Lantus SoloStar 100 Unit/mL 3mL medication to the Defense Logistics Agency (DLA). The contract, valued at $2,677.12, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 3, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,425.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 20, 2024 and was awarded on September 19, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,830,710 units of Lantus Solostar 100 Unit/mL 3mL. This $1,504.98 contract has a completion date of March 4, 2024 and does not have any set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor to deliver this pharmaceutical product in support of...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,500.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 14, 2023 and was awarded on September 13, 2023. The contract is not designated with a set-aside...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRNY9
    Delivery Order

This contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL medical supplies to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,187.60 contract has a completion date of June 12, 2023 and was awarded on June 9, 2023. This is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying essential medical commodities to federal agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 2/27/25, 11:30 AM